Laboratory testing in the evaluation and diagnosis of vasculitis

Current rheumatology reports

Volumn 2, Issue 5, 2000, Pages 417-422

  Cuellar, Marta Lucia ^a   Espinoza, Luis R ^b  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSIS, MEASUREMENT AND ANALYSIS; FEMALE; HUMAN; MALE; REVIEW; SENSITIVITY AND SPECIFICITY; STANDARD; VASCULITIS;

FEMALE; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; MALE; SENSITIVITY AND SPECIFICITY; VASCULITIS;

EID: 0034302365     PISSN: 15233774     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11926-000-0042-6     Document Type: Review

References (32)

1. 1. CA Bowles 1999 Laboratory tests in rheumatology: practical considerations Rheumatol Musculosk Med Prim Care 1 3 4 Bowles CA: Laboratory tests in rheumatology: practical considerations. Rheumatol Musculosk Med Prim Care 1999, 1:3–4.
2. 2. MH Wener 1999 Rheumatology laboratory tests Rheumatol Musculosk Med Prim Care 1 1 5 Wener MH: Rheumatology laboratory tests. Rheumatol Musculosk Med Prim Care 1999, 1:1–5.
3. 3. PA Merkel RP Polisson Y Chang 1997 Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease Ann Intern Med 126 866 873 9163287 1:STN:280:DyaK2s3pvVGktQ%3D%3D Good study regarding prevalence of ANCA in connective tissue disorders Merkel PA, Polisson RP, Chang Y, et al.: Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Ann Intern Med 1997, 126:866–873. Good study regarding prevalence of ANCA in connective tissue disorders.
4. 4. MD Cohen DL Conn 1999 Approach to the patient with suspected vasculitis Bull Rheum Dis 42 1 4 Cohen MD, Conn DL: Approach to the patient with suspected vasculitis. Bull Rheum Dis 1999, 42:1–4.
5. 5. GE Grau P Roux-Lombard C Gysler 1989 Serum cytokine changes in systemic vasculitis Immunology 68 196 198 2478451 1:STN:280:DyaK3c%2FjsFShtg%3D%3D Grau GE, Roux-Lombard P, Gysler C, et al.: Serum cytokine changes in systemic vasculitis. Immunology 1989, 68:196–198.
6. 6. RW McMurray 1998 Hepatitis C-associated autoimmune disorders Rheum Dis Clin North Am 24 353 374 9606763 10.1016/S0889-857X(05)70013-2 1:STN:280:DyaK1c3mvFKjug%3D%3D A good review of Hepatitis C-associated rheumatic disorders including mixed cryoglobulinemia McMurray RW: Hepatitis C-associated autoimmune disorders. Rheum Dis Clin North Am 1998, 24:353–374. A good review of Hepatitis C-associated rheumatic disorders including mixed cryoglobulinemia.
7. 7. RA Asherson R Cervera 1992 The antiphospholipid syndrome: a syndrome in evolution Ann Rheum Dis 51 147 150 1550393 1:STN:280:DyaK387pvVSqtA%3D%3D 10.1136/ard.51.2.147 Asherson RA, Cervera R: The antiphospholipid syndrome: a syndrome in evolution. Ann Rheum Dis 1992, 51:147–150.
8. 8. LR Espinoza LJ Jara L Silveira 1991 Anticardiolipin antibodies in polymyalgia-rheumatica-giant cell arteritis Am J Med 90 474 478 2012088 1:STN:280:DyaK3M7ovFWqsg%3D%3D Espinoza LR, Jara LJ, Silveira L, et al.: Anticardiolipin antibodies in polymyalgia-rheumatica-giant cell arteritis. Am J Med 1991, 90:474–478.
9. 9. P Duhaut M Berruyer L Pinede 1998 Anticardiolipin antibodies and giant cell arteritis: a prospective, multicenter casecontrolled study Arthritis Rheum 41 701 709 9550480 10.1002/1529-0131(199804)41:4<701::AID-ART18>3.0.CO;2-P 1:STN:280:DyaK1c3gvFymsg%3D%3D Duhaut P, Berruyer M, Pinede L, et al.: Anticardiolipin antibodies and giant cell arteritis: a prospective, multicenter casecontrolled study. Arthritis Rheum 1998, 41:701–709.
10. 10. KE Hansen KD Moore TL Ortel NG Allen 1999 Antiphospholipid antibodies in patients with Wegener’s granulomatosis and polyarteritis nodosa Arthritis Rheum 42 2250 2251 10524702 10.1002/1529-0131(199910)42:10<2250::AID-ANR32>3.0.CO;2-7 1:STN:280:DyaK1Mvlt1egsQ%3D%3D Hansen KE, Moore KD, Ortel TL, Allen NG: Antiphospholipid antibodies in patients with Wegener’s granulomatosis and polyarteritis nodosa. Arthritis Rheum 1999, 42:2250–2251.
11. 11. JC Jennette RJ Falk 1992 Disease associations and pathogenic role of antineutrophil cytoplasmic autoantibodies in vasculitis Curr Opin Rheum 4 9 15 1:STN:280:DyaK387otFynsw%3D%3D Jennette JC, Falk RJ: Disease associations and pathogenic role of antineutrophil cytoplasmic autoantibodies in vasculitis. Curr Opin Rheum 1992, 4:9–15.
12. 12. HK Choi PA Merkel JW Tervaert 1999 Alternating antineutrophil cytoplasmic antibody specialty: drug-induced vasculitis in a patient with Wegener’s granulomatosis Arthritis Rheum 42 384 388 10025935 10.1002/1529-0131(199902)42:2<384::AID-ANR22>3.0.CO;2-X 1:STN:280:DyaK1M7kvVyjsA%3D%3D Choi HK, Merkel PA, Tervaert JW, et al.: Alternating antineutrophil cytoplasmic antibody specialty: drug-induced vasculitis in a patient with Wegener’s granulomatosis. Arthritis Rheum 1999, 42:384–388.
13. 13. A Harris G Chang M Vadas D Gillis 1999 ELISA is the superior method for detecting antineutrophil cytoplasmic antibodies in the diagnosis of systemic necrotizing vasculitis J Clin Pathol 52 670 676 10655988 1:STN:280:DC%2BD3c7itFCnsw%3D%3D Harris A, Chang G, Vadas M, Gillis D: ELISA is the superior method for detecting antineutrophil cytoplasmic antibodies in the diagnosis of systemic necrotizing vasculitis. J Clin Pathol 1999, 52:670–676.
14. 14. CH Hagen MR Daha J Hermans 1997 The diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies (ANCA) in idiopathic systemic vasculitis Kidney Int 53 743 753 10.1046/j.1523-1755.1998.00807.x Useful study demonstrating the value of standardized assays for ANCA in the diagnosis of systemic vasculitis Hagen CH, Daha MR, Hermans J, et al.: The diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies (ANCA) in idiopathic systemic vasculitis. Kidney Int 1997, 53:743–753. Useful study demonstrating the value of standardized assays for ANCA in the diagnosis of systemic vasculitis.
15. 15. J Savige D Gillis E Benson 1999 International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA) Am J Clin Pathol 111 507 513 10191771 1:STN:280:DyaK1M3gslCqtw%3D%3D A very good set of guidelines on testing and interpretation of ANCA testing Savige J, Gillis D, Benson E, et al.: International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA). Am J Clin Pathol 1999, 111:507–513. A very good set of guidelines on testing and interpretation of ANCA testing.
16. 16. LCL Lim JG Taylor JL Schimtz 1999 Diagnostic usefulness of antineutrophil cytoplasmic autoantibody serology: comparative evaluation of commercial indirect fluorescent antibody kits and enzyme immunoassays kits Am J Clin Pathol 111 363 369 10078112 1:STN:280:DyaK1M7nslygug%3D%3D Useful study with practical applications on commercially available kits for ANCA testing Lim LCL, Taylor JG, Schimtz JL, et al.: Diagnostic usefulness of antineutrophil cytoplasmic autoantibody serology: comparative evaluation of commercial indirect fluorescent antibody kits and enzyme immunoassays kits. Am J Clin Pathol 1999, 111:363–369. Useful study with practical applications on commercially available kits for ANCA testing.
17. 17. J Ara M Eduardo R Rodriguez 1999 Relationship between ANCA and disease activity in small-vessel vasculitis patients with anti-MPO ANCA Nephrol Dial Transplant 14 1667 1672 10435874 10.1093/ndt/14.7.1667 1:STN:280:DyaK1Mzmt1amsA%3D%3D Very good clinical study demonstrating the value of ANCA testing in relation to disease activity in small vessel vasculitis Ara J, Eduardo M, Rodriguez R, et al.: Relationship between ANCA and disease activity in small-vessel vasculitis patients with anti-MPO ANCA. Nephrol Dial Transplant 1999, 14:1667–1672. Very good clinical study demonstrating the value of ANCA testing in relation to disease activity in small vessel vasculitis.
18. 18. AB Federici RI Fox LR Espinoza TS Zimmerman 1984 Giant cell arteritis: elevation of von Willebrand factor is independent of erythrocyte sedimentation rate and persists after steroid treatment Arthritis Rheum 24 1046 1048 10.1002/art.1780270912 Federici AB, Fox RI, Espinoza LR, Zimmerman TS: Giant cell arteritis: elevation of von Willebrand factor is independent of erythrocyte sedimentation rate and persists after steroid treatment. Arthritis Rheum 1984, 24:1046–1048.
19. 19. CG Li I Reynolds JM Ponting 1998 Serum levels of vascular endothelial growth factor (VEGF) are markedly elevated in patients with Wegener’s granulomatosis Br J Rheumatol 37 1303 1306 9973154 10.1093/rheumatology/37.12.1303 1:STN:280:DyaK1M7jslCguw%3D%3D Li CG, Reynolds I, Ponting JM, et al.: Serum levels of vascular endothelial growth factor (VEGF) are markedly elevated in patients with Wegener’s granulomatosis. Br J Rheumatol 1998, 37:1303–1306.
20. 20. MC Boffa M Karmochkine 1998 Thrombomodulin: an overview and potential implications in vascular disorders Lupus 2 S120 125 10.1177/096120339800700227 Boffa MC, Karmochkine M: Thrombomodulin: an overview and potential implications in vascular disorders. Lupus 1998, 2:S120–125.
21. 21. E Csernok A Trabandt A Muller 1999 Cytokine profiles in Wegener’s granulomatosis: predominance granulomatosis: predominance of type I (Th1) in the granulomatosis inflammation Arthritis Rheum 42 742 750 10211889 10.1002/1529-0131(199904)42:4<742::AID-ANR18>3.0.CO;2-I 1:STN:280:DyaK1M3is1yksw%3D%3D Csernok E, Trabandt A, Muller A, et al.: Cytokine profiles in Wegener’s granulomatosis: predominance granulomatosis: predominance of type I (Th1) in the granulomatosis inflammation. Arthritis Rheum 1999, 42:742–750.
22. 22. MA Frassanito R Dammacco P Cafforio F Dammacco 1999 Th1 polarization of the immune response in Behcet’s disease Arthritis Rheum 42 1967 1974 10513814 10.1002/1529-0131(199909)42:9<1967::AID-ANR24>3.0.CO;2-Z 1:CAS:528:DyaK1MXmsl2msLY%3D Frassanito MA, Dammacco R, Cafforio P, Dammacco F: Th1 polarization of the immune response in Behcet’s disease. Arthritis Rheum 1999, 42:1967–1974.
23. 23. M Noris E Daina S Gambas 1999 Interleukin-6 and RANTES in takayasu arteritis: a guide for therapeutic decisions Circulation 100 55 60 10393681 1:STN:280:DyaK1Mzit1Clsg%3D%3D Noris M, Daina E, Gambas S, et al.: Interleukin-6 and RANTES in takayasu arteritis: a guide for therapeutic decisions ? Circulation 1999, 100:55–60.
24. 24. E Uchio T Matsumoto SI Tanaka S Ohno 1999 Soluble intercellular adhesion molecule-1 (ICAM-1), CD4, CD8 and interleukin-2 receptor in patients with Behcet’s disease and Vogt-Koyanagi-Harada’s disease Clin Exp Rheumatol 17 179 184 10342043 1:STN:280:DyaK1M3ntlGruw%3D%3D Uchio E, Matsumoto T, Tanaka SI, Ohno S: Soluble intercellular adhesion molecule-1 (ICAM-1), CD4, CD8 and interleukin-2 receptor in patients with Behcet’s disease and Vogt-Koyanagi-Harada’s disease. Clin Exp Rheumatol 1999, 17:179–184.
25. 25. AG Zaman C Edelsten MR Stanford 1994 Soluble intercellular adhesion molecule-1 (ICAM-1) as a marker of disease relapse in idiopathic uveoretinits Clin Exp Immunol 95 60 65 7507016 1:CAS:528:DyaK2cXhvVymu7Y%3D 10.1111/j.1365-2249.1994.tb06015.x Zaman AG, Edelsten C, Stanford MR, et al.: Soluble intercellular adhesion molecule-1 (ICAM-1) as a marker of disease relapse in idiopathic uveoretinits. Clin Exp Immunol 1994, 95:60–65.
26. 26. E Bernacchi LL Cirita M Caproni 1999 Hepatitis C virus (HCV) in cryoglo-bulinemic leukocytoclastic vasculitis (LCV): could the presence of HCV in skin lesions be related to T CD8+ lymphocytes, HLA-DR and ICAM-1 expression Exp Dermatol 8 480 486 10597137 10.1111/j.1600-0625.1999.tb00306.x 1:STN:280:DC%2BD3c%2Fmt1aksQ%3D%3D Bernacchi E, Cirita LL, Caproni M, et al.: Hepatitis C virus (HCV) in cryoglo-bulinemic leukocytoclastic vasculitis (LCV): could the presence of HCV in skin lesions be related to T CD8+ lymphocytes, HLA-DR and ICAM-1 expression ? Exp Dermatol 1999, 8:480–486.
27. 27. SR Fernandes MB Bertolo CL Rossi 1999 Polyarteritis nodosa and cytomygolo-virus: diagnosis by polymerase chain reaction Clin Rheumatol 18 501 503 10638780 10.1007/s100670050148 1:STN:280:DC%2BD3c7gt1eiug%3D%3D Fernandes SR, Bertolo MB, Rossi CL, et al.: Polyarteritis nodosa and cytomygolo-virus: diagnosis by polymerase chain reaction. Clin Rheumatol 1999, 18:501–503.
28. 28. K Aksu Y Kabasakal A Sayiner 1999 Prevalences of hepatitis A, B, C, and E viruses in Behcet’s disease Rheumatology 38 1279 1281 10587560 10.1093/rheumatology/38.12.1279 1:STN:280:DC%2BD3c%2Fls1CgsA%3D%3D Aksu K, Kabasakal Y, Sayiner A, et al.: Prevalences of hepatitis A, B, C, and E viruses in Behcet’s disease. Rheumatology 1999, 38:1279–1281.
29. 29. AW Stenson 1990 Roentgenographic findings in major vasculitc syndromes Rheum Dis Clin North Am 16 293 308 Very good review on typical angiographic findings in systemic vasculitis Stenson AW: Roentgenographic findings in major vasculitc syndromes. Rheum Dis Clin North Am 1990, 16:293–308. Very good review on typical angiographic findings in systemic vasculitis.
30. 30. S Avrigucci G Fantozzi F Riello 1998 Horton’s temporal arteritis: diagnosis using color Doppler ultrasonography Minverva Cardioangiol 46 345 346 Avrigucci S, Fantozzi G, Riello F, et al.: Horton’s temporal arteritis: diagnosis using color Doppler ultrasonography. Minverva Cardioangiol 1998, 46:345–346.
31. 31. CJ Jennette DM Milling RJ Falk 1994 Vasculitis affecting the skin. A review Arch Dermatol 130 899 906 8024277 10.1001/archderm.130.7.899 1:STN:280:DyaK2c3ps1SrtA%3D%3D Jennette CJ, Milling DM, Falk RJ: Vasculitis affecting the skin. A review. Arch Dermatol 1994, 130:899–906.
32. 32. A Alrawi JD Trobe M Blaivas DC Musch 1999 Brain biopsy in primary angiitis of the central nervous system Neurology 53 858 860 10489055 1:STN:280:DyaK1MvhslWrsg%3D%3D Alrawi A, Trobe JD, Blaivas M, Musch DC: Brain biopsy in primary angiitis of the central nervous system. Neurology 1999, 53:858–860.